Cargando…
Enhanced osteogenesis and therapy of osteoporosis using simvastatin loaded hybrid system
Postmenopausal osteoporosis is a common chronic dynamic bone disorder, caused by estrogen deficiency. To address this issue, we constructed a controlled drug-release system composed of poly (N-isopropylacrylamide) brush modified mesoporous hydroxyapatite (MHA-SIM-P) loaded with simvastatin (SIM) usi...
Autores principales: | Wu, Tao, Sun, Jing, Tan, Lei, Yan, Qi, Li, Lei, Chen, Liangwen, Liu, Xiangmei, Bin, Shi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078127/ https://www.ncbi.nlm.nih.gov/pubmed/32206736 http://dx.doi.org/10.1016/j.bioactmat.2020.03.004 |
Ejemplares similares
-
Effect of simvastatin on osteogenesis of the lumbar vertebrae in ovariectomized rats
por: Long, Teng, et al.
Publicado: (2016) -
A novel biocompatible, simvastatin-loaded, bone-targeting lipid nanocarrier for treating osteoporosis more effectively
por: Tao, Shan, et al.
Publicado: (2020) -
Simvastatin Enhances the Chondrogenesis But Not the Osteogenesis of Adipose-Derived Stem Cells in a Hyaluronan Microenvironment
por: Wu, Shun-Cheng, et al.
Publicado: (2021) -
Enhanced osteogenesis and angiogenesis by mesoporous hydroxyapatite microspheres-derived simvastatin sustained release system for superior bone regeneration
por: Yu, Wei-Lin, et al.
Publicado: (2017) -
Correction: A novel biocompatible, simvastatin-loaded, bone-targeting lipid nanocarrier for treating osteoporosis more effectively
por: Tao, Shan, et al.
Publicado: (2020)